4SC AG
🏢 View company profile →52Patents
37Active
52Granted
47Portfolio score
Filing activity: Oct 20, 2000 → Mar 26, 2019 · 27 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7247736B2 | Method of identifying inhibitors of DHODH | Emerging Cross-Sectional Technologies | 88 | Expired |
| US7071355B2 | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | Chemistry; Metallurgy | 86 | Expired |
| US7365094B2 | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | Chemistry; Metallurgy | 84 | Expired |
| US8575193B2 | N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds | Chemistry; Metallurgy | 41 | Active |
| US8207174B2 | Aryloxypropanolamines, methods of preparation therof and use of aryloxypropanolamines as medicaments | Chemistry; Metallurgy | 18 | Active |
| US7666868B2 | N-sulphonylpyrroles and their use as histone deacetylase inhibitors | Chemistry; Metallurgy | 12 | Expired |
| US7423057B2 | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | Chemistry; Metallurgy | 7 | Expired |
| US7601745B2 | Heterocyclic NF-kB inhibitors | Chemistry; Metallurgy | 7 | Active |
| US8354433B2 | Anti-inflammatory agents as virostatic compounds | Emerging Cross-Sectional Technologies | 6 | Active |
| US9951050B2 | Method of inhibiting DYRK1B | Human Necessities | 6 | Active |
| US7176241B2 | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | Chemistry; Metallurgy | 5 | Expired |
| US6949567B2 | Compounds for the treatment of protozoal diseases | Chemistry; Metallurgy | 4 | Expired |
| US8557991B2 | Process for preparing enantiomerically pure indolopyridines | Chemistry; Metallurgy | 3 | Active |
| US7812041B2 | Heterocyclic NF-κB inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7514460B2 | Benzazole analogues and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10005769B2 | 2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors | Human Necessities | 2 | Active |
| US9073913B2 | Substituted imidazoquinolines | Emerging Cross-Sectional Technologies | 2 | Active |
| US9908880B2 | Substituted imidazoquinolines | Emerging Cross-Sectional Technologies | 2 | Active |
| US8969401B2 | Sulfonylpyrroles | Chemistry; Metallurgy | 1 | Active |
| US6727100B1 | Method of identifying candidate molecules | Physics | 1 | Expired |
| US8440830B2 | Tetrahydro-fused pyridines as histone deacetylase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8188138B2 | Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors | Human Necessities | 1 | Active |
| US9446040B2 | Substituted imidazoquinolines | Emerging Cross-Sectional Technologies | 1 | Active |
| US7842820B2 | Sulfonylpyrroles | Chemistry; Metallurgy | 1 | Active |
| US7803945B2 | Tetrahydropyridothiophenes | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.